NeuroBo Pharmaceuticals's total assets for Q3 2024 were $22.15M, a decrease of -22.97% from the previous quarter. NRBO total liabilities were $9.19M for the fiscal quarter, a -6.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.